NYSE · Drug Manufacturers - General

Eli Lilly and Company (LLY)

$1,152.93 +0.04%
47 In band Daily RSI (14) · 18 Sep 2026

Moving averages

SMA 50$1,176.50+115,193.00%
SMA 200$1,064.17+115,193.00%
EMA 20$1,156.46+115,193.00%

Company profile

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.

SectorHealthcare
IndustryDrug Manufacturers - General
Market cap$1.00T
P/E ratio37.75
EPS$29.78
Beta0.502
Dividend yield0.57%
52-week high$1,292.65
52-week low$707.59

Insider transactions

ExecutiveTitleActionSharesDate
SEYMOUR, MELISSAEVP, Global QualitySell122026-09-09
DOZIER, ERICEVP, Chief People OfficerSell2162026-09-02
HERNANDEZ, EDGARDOEVP & Pres., Mfg. OperationsSell132026-09-02
Unlock insider transactions

Latest news

Earnings call transcript

Q2 2026

Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q2 2026 Earnings Conference Call. I would now like to turn the conference over to your host, Mike Czapar, Senior Vice President of Investor Relations. Please go ahead.…

Unlock the earnings call transcript

Options chain

TypeStrikeExpiryVolumeOpen interest
Put$520.002026-10-162,7293,193
Call$1,200.002026-09-189292,177
Put$1,100.002026-09-187901,286
Unlock the options chain

Similar stocks in Drug Manufacturers - General

Free forever

RSI alerts for LLY

Get an email the moment Eli Lilly and Company crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 19 September 2026 at 11:58 PM EDT